1977
DOI: 10.1099/00221287-100-2-283
|View full text |Cite
|
Sign up to set email alerts
|

The Mechanism of Action of Nitro-heterocyclic Antimicrobial Drugs. Metabolic Activation by Micro-organisms

Abstract: Although the target of the antimicrobial drug 1-methyl-2-nitro-5-vinylimidazole (MEV) has been shown to be DNA (Goldstein et al., 1977) the drug was ineffective in cell-free systems because it was not activated. Both the rate of metabolic activation of MEV and its antibacterial activity were increased when bacteria were grown in limiting oxygen. Mutants of Escherichid coli which were conditionally resistant to nitroimidazoles and nitrofurans were defective in drug activation. The activities of these drugs agai… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

1977
1977
2004
2004

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 21 publications
(7 citation statements)
references
References 31 publications
0
7
0
Order By: Relevance
“…26 Nitrofurantoin has also been reported to possess a novel mechanism that does not require the production of reactive metabolites by bacterial reductases 8 , . 27 Based on these results and the fact that the degree of reduction required differs, we speculate that the nitroreduction of nitrofurantoin requires the interaction of one or more putative H. pylori nitroreductases that are also required for high level metronidazole resistance.…”
Section: Discussionmentioning
confidence: 83%
“…26 Nitrofurantoin has also been reported to possess a novel mechanism that does not require the production of reactive metabolites by bacterial reductases 8 , . 27 Based on these results and the fact that the degree of reduction required differs, we speculate that the nitroreduction of nitrofurantoin requires the interaction of one or more putative H. pylori nitroreductases that are also required for high level metronidazole resistance.…”
Section: Discussionmentioning
confidence: 83%
“…The mechanism by which a molecule such as MEV might induce cross-links is not imme-280 B. P. GOLDSTEIN AND OTHERS diately obvious. Our studies of MEV (Goldstein et al, 1977) and work on other nitroheterocyclic drugs (McCalla et al, 1970;Ings et al, 1974) indicate that reactive compounds are evolved, within sensitive micro-organisms, by reduction of the nitro-drugs to their nitroso-and hydroxylamino-derivatives. Such reactive compounds might induce crosslinking indirectly (Fishbein, Flamm & Falk, 1970;Bautz Freese et al, 1967).…”
Section: ~6 9mentioning
confidence: 82%
“…Such reactive compounds might induce crosslinking indirectly (Fishbein, Flamm & Falk, 1970;Bautz Freese et al, 1967). On the other hand, we have observed incorporation of 14C-labelled MEV metabolites into the cold TCA-precipitable fraction of treated bacteria (Goldstein et al, 1977) and another nitroimidazole, metronidazole, reportedly bound to DNA and proteins in Trichomonas vaginalis on metabolic activation (Ings et al, 1974). In the case of MEV, it is possible that oxidation of the vinyl moiety to the epoxide could provide a second reactive site on the molecule, allowing it to bridge two DNA strands (a suggestion made by M. Calvin).…”
Section: ~6 9mentioning
confidence: 98%
“…Simple inter- calating agents that do not react covalently with DNA (hycanthone and ICR 191) show a limited differential inhibition. Several known premutagens with nitro groups (1-methyl-2-nitro-5-vinylimidazole, nitrofurantoin, nitrofurazone, and 4nitroquinoline-N-oxide) are active in the rec assay in the absence of externally supplied metabolic activation, indicating that microbial nitroreductases are able to produce ultimate mutagens, detected as DNA-damaging agents (4,15,16). A strong limitation of the rec assay is the lack of a protocol for efficient metabolic activation of premutagens other than nitro compounds.…”
Section: Resultsmentioning
confidence: 99%